Overview Fundamentals API Earnings EOD API Sample Code Pricing

DURECT CORP. DL-001 (DC8A F) stock market data APIs

€1.16 0.02(1.8%) as of November 1, 2024
Price chart is built with Anychart

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

DURECT CORP. DL-001 Financial Data Overview

1.14
1.16
-
1.16
1.14
0.408-2.38
38 215 K
31 039 K
8 411 K
1.134
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'DC8A',
Type: 'Common Stock',
Name: 'DURECT CORP. DL-001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
CUSIP: NULL,
}

DURECT CORP. DL-001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 8 411 K
  • EBITDA -24 930 000
  • Earnings Per Share -0.56
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get DURECT CORP. DL-001 Earnings via APIs

  • Latest Release 2024-08-13
  • EPS/Forecast NaN

Get DURECT CORP. DL-001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com